August 18, 2021
Fredericksburg, VA (August 18, 2021) – Mary Washington Hospital now offers a new miniaturized, wireless
monitoring sensor to manage heart failure (HF). The Abbott CardioMEMS™
HF System is the first and only FDA-approved heart failure monitoring
device clinically proven to significantly reduce hospital admissions when
used by physicians to manage heart failure.
Heart failure is the leading cause of hospitalization for Americans over
age 65. It occurs when the heart is unable to pump enough blood to meet
the body’s demands. This device allows patients to remotely share
daily sensor readings from their homes with their health care providers,
allowing for personalized care that reduces the likelihood of hospitalization.
Innovative telehealth, like the CardioMEMS HF System, reduces the need
for in-person appointments. Data from a recent clinical trial found that
the remote monitoring technology reduces heart failure hospital admissions
by up to 58 percent.
“This innovative technology provides us the ability to monitor heart
failure patients from the comfort of their homes, improving outcomes and
quality of life,” said Ashok J. Prasad, MD, Interventional Cardiologist,
who performed the first CardioMEMS procedure at Mary Washington Hospital.
“Continued investment in new procedures like CardioMEMS is a tremendous
benefit to patients and families as we strive to find the latest solutions
to meet the growing healthcare needs of our community.”
Cynthia, from Fredericksburg, Virginia, was Dr. Prasad’s first patient
to receive the CardioMEMS monitoring device, which was implanted at Mary
Washington Hospital earlier this year.
View her story here.
The CardioMEMS HF System, from global health care leader Abbott, is approved
by the U.S. Food and Drug Administration (FDA) for commercial use in the
U.S. The GUIDE-HF clinical trial followed the CHAMPION trial, which studied
the effectiveness of the CardioMEMS HF System in New York Heart Association
(NYHA) Functional Classification System class III heart failure patients
who had been hospitalized for heart failure in the previous 12 months.
According to the American Heart Association, nearly 6 million Americans
have heart failure, and 900,000 new patients are diagnosed each year.
The Centers for Disease Control and Prevention cite that half of heart
failure patients die within five years of diagnosis. The estimated cost
of heart failure in the U.S. is expected to double by 2030.
For more information about cardiac care at Mary Washington Healthcare,
please visit heart.mwhc.com.
About Mary Washington Healthcare:
Mary Washington Healthcare is a fully integrated, regional medical system
that provides inpatient and outpatient care through over 50 facilities
including Mary Washington Hospital, a 471-bed regional medical center,
and Stafford Hospital, a 100-bed community hospital. Mary Washington Healthcare
is a non-profit health system with a longstanding commitment to provide
care regardless of ability to pay. For more information about our services
and facilities, visit mwhc.com.
Abbott is a global healthcare leader that helps people live more fully
at all stages of life. Our portfolio of life-changing technologies spans
the spectrum of healthcare, with leading businesses and products in diagnostics,
medical devices, nutritional’s and branded generic medicines. Our
107,000 colleagues serve people in more than 160 countries.